Data as of 9:57am ET
| +0.12 / +4.08%|
The 4 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +226.80% increase from the last price of 3.06.
The current consensus among 4 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.